Literature DB >> 19048257

Hyperuricemia and its related factors in an urban population, Izmir, Turkey.

Ismail Sari1, Servet Akar, Betul Pakoz, Ali Riza Sisman, Oguz Gurler, Merih Birlik, Fatos Onen, Nurullah Akkoc.   

Abstract

The aim of this study was to examine the prevalence of hyperuricemia and its associated factors in an urban area of Izmir, located in western Turkey. Our study group was selected by computerized sampling from the participants of a larger population-based study searching for the prevalence of rheumatoid arthritis in Balcova and Narlidere districts of Izmir. A total of 132 subjects (69 women and 63 men) were included in this study. Serum uric acid, glucose, creatinine and lipid levels were studied. Body composition along with body fat percentage was determined anthropometrically. A total of 16 subjects had hyperuricemia (4 women and 12 men). The overall prevalence of hyperuricemia was 12.1% and the mean uric acid level was 4.9 +/- 1.3 mg/dl. Males had significantly higher uric acid levels than females (P < 0.05; 5.5 +/- 1.3 vs. 4.3 +/- 1.1 mg/dl, respectively). The prevalence of hypertension, diabetes, obesity and metabolic syndrome was 24.4, 5.3, 28 and 26.5%, respectively. There was no gouty subject. Sum of skinfold thickness (SFT) measurements and creatinine levels were the independent predictors of hyperuricemia (beta = 0.45, 0.47, respectively). Uric acid measurement is important not only for inflammatory rheumatic disorders but also for predicting metabolic syndrome and related coronary artery disease. There is sex difference in uric acid levels in favor of women most probably explained by gonadal hormones. Hyperuricemia is significantly predicted by anthropometric measure of SFT which is a simple clinical screening method along with creatinine levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048257     DOI: 10.1007/s00296-008-0806-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 3.  Epidemiology of hyperuricemia and gout.

Authors:  Andrew J Luk; Peter A Simkin
Journal:  Am J Manag Care       Date:  2005-11       Impact factor: 2.229

4.  Systolic, diastolic, and pulse pressures as coronary risk factors in a population with low cholesterol levels: a prospective 10-year evaluation.

Authors:  Altan Onat; Köksal Ceyhan; Burak Erer; Omer Başar; Omer Uysal; Vedat Sansoy
Journal:  Clin Cardiol       Date:  2003-02       Impact factor: 2.882

5.  The prevalence of metabolic syndrome among young adults in Izmir, Turkey.

Authors:  Ahmet Soysal; Yücel Demiral; Dilek Soysal; Reyhan Uçku; Mehmet Köseoğlu; Gazanfer Aksakoğlu
Journal:  Anadolu Kardiyol Derg       Date:  2005-09

6.  Serum uric acid is a determinant of metabolic syndrome in a population-based study.

Authors:  Altan Onat; Hüseyin Uyarel; Gülay Hergenç; Ahmet Karabulut; Sinan Albayrak; Ibrahim Sari; Mehmet Yazici; Ibrahim Keleş
Journal:  Am J Hypertens       Date:  2006-10       Impact factor: 2.689

7.  Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men.

Authors:  N Nakanishi; H Yoshida; K Nakamura; K Suzuki; K Tatara
Journal:  Metabolism       Date:  2001-06       Impact factor: 8.694

8.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

Review 9.  Primary prevention in rheumatology: the importance of hyperuricemia.

Authors:  Janitzia Vázquez-Mellado; Everardo Alvarez Hernández; Rubén Burgos-Vargas
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-04       Impact factor: 4.098

10.  Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.

Authors:  S Yavuz Sanisoglu; Cagatay Oktenli; Adnan Hasimi; Mehmet Yokusoglu; Mehmet Ugurlu
Journal:  BMC Public Health       Date:  2006-04-10       Impact factor: 3.295

View more
  19 in total

Review 1.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

2.  Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Authors:  Lisa K Stamp; Puja P Khanna; Nicola Dalbeth; Maarten Boers; Walter P Maksymowych; H Ralph Schumacher; Michael A Becker; Patricia A MacDonald; N Lawrence Edwards; Jasvinder A Singh; Lee S Simon; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Vibeke Strand; William J Taylor
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

3.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

4.  Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis.

Authors:  Sıdıka Gülkan Özkan; Hatice Yazısız; Ahmet Behlül; Yüksel Aslı Gökbelen; Fatih Borlu; Veli Yazısız
Journal:  Eur J Rheumatol       Date:  2017-03-01

5.  Prevalence of Hyperuricemia and the Relationship Between Serum Uric Acid and Hypertension in New Onset Diabetic Patients: A Cross-Sectional Indian Study.

Authors:  Shailendra Kumar Singh; Rina Singh; Santosh Kumar Singh; Mir Asif Iquebal; Sarika Jaiswal; Archana Singh
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-14       Impact factor: 3.249

6.  Demographic and clinical features of gout patients in Turkey: a multicenter study.

Authors:  Mehmet Akif Öztürk; Arif Kaya; Soner Şenel; Salim Dönmez; Ayşe Balkarlı; Veli Çobankara; Çiğdem Erhan; Mehmet Sayarlıoğlu; Yunus Ugan; Ş Ercan Tunç; Yavuz Pehlivan; Bünyamin Kısacık; Abdurrahman Tufan; Ahmet Mesut Onat; Engin Tezcan; Gözde Yıldırım Çetin; Omer Nuri Pamuk
Journal:  Rheumatol Int       Date:  2012-05-16       Impact factor: 2.631

Review 7.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

8.  A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population.

Authors:  Qian Zhang; Chengqi Zhang; Xinhong Song; Haiyan Lin; Dongzhi Zhang; Wenjia Meng; Yongyuan Zhang; Zhenxin Zhu; Fang Tang; Longjian Liu; Xiaowei Yang; Fuzhong Xue
Journal:  BMC Public Health       Date:  2012-06-08       Impact factor: 3.295

9.  The prevalence of hyperuricemia in China: a meta-analysis.

Authors:  Liu B; Wang T; Zhao Hn; Yue Ww; Yu Hp; Liu Cx; Yin J; Jia Ry; Nie Hw
Journal:  BMC Public Health       Date:  2011-10-27       Impact factor: 3.295

Review 10.  Hyperuricaemia in the Pacific: why the elevated serum urate levels?

Authors:  Anna L Gosling; Elizabeth Matisoo-Smith; Tony R Merriman
Journal:  Rheumatol Int       Date:  2013-12-31       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.